List view / Grid view
30 August 2018 | By Iqra Farooq (European Pharmaceutical Review)
Researchers have developed an electronic device which could help to detect, prevent and stop seizures from occurring in epileptic patients...
21 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Cannabidiol was shown in a new large-scale, randomised, controlled trial to significantly reduce the number of dangerous seizures in patients with a severe form of epilepsy...
15 May 2018 | By European Pharmaceutical Review
The approval provides paediatric epilepsy patients a treatment option which can be initiated at a therapeutic dose from day one...
8 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
A naturally occurring compound found in cannabis may help to curb the frequency of epileptic seizures...
6 November 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
FDA approves Vimpat for partial-onset seizures in paediatric epilepsy patients as an oral solution or a convenient tablet...
22 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
UCB has announced that the EC has approved the use of its anti-epileptic drug Vimpatas in the treatment of partial-onset seizures...
7 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Neuroscientists have found that cannabidiol reduces symptoms such as impaired memory in adolescent mice simultaneously exposed to THC...
18 August 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have connected docosahexaenoic (DHA) synthesis to oestrogen production and consequentially brain health...
7 August 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Cannabidiol is being studied as a potential anticonvulsant, and it has demonstrated effectiveness in animal models of epilepsy and in humans...
13 April 2017 | By Niamh Marriott, Junior Editor
A new childhood absence epilepsy study has identified genes that show individual reactions and could be used as a precision medicine approach...
22 March 2017 | By Niamh Marriott, Junior Editor
HempMeds Mexico has revealed the positive results of a recent cannabis study conducted on the effects of the Real Scientific Hemp Oil-X...
18 November 2016 | By Niamh Louise Marriott, Digital Content Producer
E is for Epilepsy - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research on Epilepsy...
27 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Clobazam oral suspension is used principally as an adjunctive therapy for epilepsy with the formulation particularly suitable for children and young adults...
21 June 2016 | By Victoria White, Digital Content Producer
GW Pharmaceuticals has selected infantile spasms as the fourth target indication for its Epidiolex orphan paediatric epilepsy development programme...
24 March 2016 | By Victoria White
Aprecia’s Spritam (levetiracetam) tablets, for oral suspension, are now available in the US as an adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalized tonic-clonic seizures.
Follow: